IGM Biosciences, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IGM Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • IGM Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$47.9M, a 25.6% increase year-over-year.
  • IGM Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$220M, a 5.95% increase year-over-year.
  • IGM Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$246M, a 11.4% decline from 2022.
  • IGM Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$221M, a 33.9% decline from 2021.
  • IGM Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$165M, a 103% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$246M -$25.3M -11.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$221M -$55.9M -33.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$165M -$83.8M -103% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 -$81.4M -$38.2M -88.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-30
2019 -$43.1M -$20.4M -89.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 -$22.7M -$11.7M -105% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 -$11.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.